Abiopharma

ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

BranchOut Food Inc. Announces Fourth Quarter and Full Year 2025 Earnings Call and Shareholder Update

Axos Financial, Inc. to Announce Third Quarter Fiscal 2026 Results on April 30, 2026

Empery Digital Rejects Invalid Nomination Notices from Dissident Stockholders

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

One and One Green Technologies. INC Launches Luzon Copper-Gold Ore Tailings Slag Venture to Address Projected 150,000-Ton Global Copper Supply Deficit

Norwegian Cruise Line Holdings Announces Board Refreshment

Blackstone Mortgage Trust Announces First-Quarter 2026 Earnings Release and Conference Call

Net Asset Value(s)

Summit Plc - Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026